The uncertain role of thrombolytic therapy in the treatment of pulmonary embolism.

نویسنده

  • James E Dalen
چکیده

IED20006 THE FIRST clinical report of the use of a thrombolytic agent (streptokinase) to treat acute pulmonary embolism (PE) appeared in 1964,1 and the first randomized clinical trial comparing urokinase plus heparin with heparin alone was published in 1970.2 A randomized clinical trial comparing urokinase to streptokinase in the treatment of PE was published in 1974.3 The first report of a third thrombolytic agent, recombinant tissue-type plasminogen activator, in the treatment of acute PE was published by Bounameaux et al4 in 1985. The US Food and Drug Administration approved streptokinase in 1977, urokinase in 1978, and recombinant tissuetype plasminogen activator in 1990 for the treatment of acute PE.5 Despite more than 3 decades of experience with these thrombolytic agents, their role in the treatment of PE remains uncertain and controversial.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Prognostic Impact of Thrombolysis in Myocardial Infarction Risk Index on Hospitalization Mortality of Patient with Acute Pulmonary Embolism

Introduction: Acute pulmonary embolism (PE) is one of the deadly cardiovascular diseases. One of the indexes proposed in these patients for risk stratification is the Thrombolysis in Myocardial Infarction (TIMI) risk index (TRI), which includes three parameters of systolic blood pressure, age, and heart rate. This study aimed to evaluate the predictive value of TRI on in-hospit...

متن کامل

Periodontal Pockets as a Potential Source of Infection: a Case of Possible Odontogenic Septic Pulmonary Embolism

Although dental foci can be sources of bacteremia and bacterial endocarditis, hematogenous spread of infection presented with septic pulmonary embolism apparently is rare. The occurrence of septic pulmonary embolism in patients with periodontal disease without suppurative thrombophlebitis of the great vessels of the neck is well documented but to our knowledge, there is no report on septic pulm...

متن کامل

Incidental Pulmonary Embolism in Cancer Patients: A Single-Institution Analysis in Panama

Introduction: Incidental pulmonary embolisms (iPE) are common in cancer patients. Studies addressing iPE in oncology are increasing; however, few of these investigations have been conducted in a Latin-American population. This study aims to describe the incidence and characteristics of iPE in cancer patients in a comprehensive cancer center from Panama. Methods: A single-center, retrospective stud...

متن کامل

Diagnosis of thromboembolic disease: Combined ventilation perfusion lung scan and compression ultrasonography

The clinical management of pulmonary embolism and deep venous thrombosis of the legs are similar and requires prolonged anticoagulation therapy. The standard diagnostic approach in patients suspected of pulmonary embolism is ventilation-perfusion (V/Q) lung scan and compression ultrasonography to detect deep venous thrombosis. This retrospective study analyzed the role of V/Q lung scan an...

متن کامل

Massive pulmonary embolism: the place for embolectomy

Untreated massive pulmonary embolism is associated with a high mortality. Pulmonary embolectomy has been largely superceded by thrombolytic therapy, but there are cases in which pulmonary embolectomy remains the treatment of choice. We present three case reports and discuss the merits of the various treatments available for massive pulmonary embolism. The primary treatment of massive pulmonary ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Archives of internal medicine

دوره 162 22  شماره 

صفحات  -

تاریخ انتشار 2002